Beyond Obesity: Orforgliprons Expanding Pipeline In addition to its approved obesity indication, orforglipron is being investigated across a range of metabolic and cardiometabolic conditions, including type 2 diabetes, obstructive sleep apnoea, osteoarthritis knee pain, hypertension, peripheral artery disease, and stress urinary incontinence
Smp24, a scorpion-venom peptide, exhibits potent antitumor effects against hepatoma HepG2 cells via multi-mechanisms in vivo and in vitro
Managing Wegovy hair loss A small number of Wegovy users may experience temporary hair loss, also known as telogen effluvium
Here are your next steps Given the risks and drawbacks mentioned above, along with the absence of long-term safety data on PT 141, it is essential to consult your urologist before deciding to take it